GlassScriptPhysician profile
Richard B Polakoff
NPI 1356315303
$9,033.33
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,009 · 2020: $1,213 · 2021: $2,293 · 2022: $1,164 · 2023: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,607.11 | 2019-2023 | |
| Novo Nordisk INC | $1,320.33 | 2019-2023 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $943.63 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $936.43 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $754.00 | 2019-2022 | |
| Abbott Laboratories | $679.80 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $648.61 | 2019-2023 | Xarelto |
| Lilly USA, LLC | $434.70 | 2019-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $361.02 | 2019-2021 | |
| Medtronic Vascular, INC. | $166.36 | 2019 | |
| Novartis Pharmaceuticals Corporation | $154.15 | 2019 | |
| Heartflow, INC. | $125.00 | 2022 | |
| Allergan, INC. | $125.00 | 2020 | |
| Mylan Specialty L.P. | $124.99 | 2021 | |
| Vifor Pharma, INC. | $124.99 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $124.53 | 2019 | |
| Ethicon US, LLC | $113.64 | 2019 | |
| Merck Sharp & Dohme LLC | $102.02 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.71 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.10 | 2022-2023 | Xifaxan |
| Pfizer INC. | $38.55 | 2022-2023 | |
| Corcept Therapeutics | $17.40 | 2021 | |
| Amarin Pharma, INC. | $15.98 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Polakoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.